BioInsights - Leveraging the power of AI to design the best performing iPSC culture media

Leveraging the power of AI to design the best performing iPSC culture media

Cell & Gene Therapy Insights 2022; 8(9), 1137;

DOI: 10.18609/cgti.2022.168

Published: 15 September 2022
FastFacts
Asma Ayari


  • You will learn how to automatically create custom and optimized media formulations based on peer-reviewed research for induced pluripotent stem cell (iPSC)-based therapy
  • Independent of the cell type used in your process, learn how you can improve key critical quality attributes related to your therapy by having a customized media formulation
  • Learn how to maintain IP ownership of the formulations you create and easily order them in the preferred format, size, and packaging to reduce cost and mitigate supply chain risks
  • Instantly canvas publicly accessible scientific content and extract component and concentration level information to dramatically reduce the time to research and design custom formulations

Dr Asma Ayari is Nucleus Biologics' Head of R&D, running Formulation Services & Product Development and has extensive experience in media analysis, testing and formulation for Cell and Gene Therapy. Asma did her PhD work in virology and immunology and brings a deep understanding of how complex cellular systems are affected by small changes in the chemical composition of the microenvironment. Dr Ayari holds a MSc. in Microbiology from University of Tunis and a PhD in Virology, Immunology and Metabolism from University of Lille in France.








We hope you enjoyed this FastFacts video. You can also view the summary here.





Authorship & Conflict of Interest

Contributions: The named author takes responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.

Acknowledgements: None

Disclosure and potential conflicts of interest: The author has no conflicts of interest to disclose. 

Funding declaration: The author received no financial support for the research, authorship and/or publication of this article. 


Article & copyright information

Copyright: Published by Cell and Gene Therapy Insights under Creative Commons License Deed CC BY NC ND 4.0 which allows anyone to copy, distribute, and transmit the article provided it is properly attributed in the manner specified below. No commercial use without permission.

Attribution: Copyright © 2022 Cytiva. Published by Cell and Gene Therapy Insights under Creative Commons License Deed CC BY NC ND 4.0.

Article source: From a FastFacts video recorded on: Sep 02 2022; Publication date: 03 Oct 2022.